Content deleted Content added
No edit summary Tags: Visual edit Mobile edit Mobile web edit |
Citation bot (talk | contribs) Altered template type. Removed Template redirect. | Use this bot. Report bugs. | #UCB_CommandLine |
||
| (2 intermediate revisions by 2 users not shown) | |||
Line 3:
{{Use dmy dates|date=June 2020}}
{{Infobox interventions |
| Name = S.G.O.T. (ALT), S.G.P.T. (AST)
| Image =
| Caption = Liver function and its markers raised in different conditions
Line 15:
'''Liver function tests''' ('''LFTs''' or '''LFs'''), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's [[liver]].<ref name="Lee2009">{{cite book|last=Lee|first=Mary|title=Basic Skills in Interpreting Laboratory Data|url=https://books.google.com/books?id=AUSIRcV_as0C&pg=PA259|access-date=5 August 2011|date=2009-03-10|publisher=ASHP|isbn=978-1-58528-180-0|page=259}}</ref> These tests include [[prothrombin time]] (PT/INR), [[activated Partial Thromboplastin Time|activated partial thromboplastin time]] (aPTT), [[albumin]], [[bilirubin]] (direct and indirect), and others. The liver transaminases [[Aspartate transaminase|aspartate transaminase (AST or SGOT)]] and [[Alanine transaminase|alanine transaminase (ALT or SGPT)]] are useful biomarkers of liver injury in a patient with some degree of intact liver function.<ref name="pmid10221307">{{cite journal | author = Johnston DE | title = Special considerations in interpreting liver function tests | journal = Am Fam Physician | volume = 59 | issue = 8 | pages = 2223–30 | year = 1999 | pmid = 10221307 }}</ref><ref name="McClatchey2002">{{cite book|last=McClatchey|first=Kenneth D.|title=Clinical laboratory medicine|url=https://books.google.com/books?id=3PJVLH1NmQAC&pg=PA288|year=2002|publisher=Lippincott Williams & Wilkins|isbn=978-0-683-30751-1|page=288}}</ref><ref name="MengelSchwiebert2005">{{cite book|last1=Mengel|first1=Mark B.|last2=Schwiebert|first2=L. Peter|title=Family medicine: ambulatory care & prevention|url=https://books.google.com/books?id=XvLo7xvmFo0C&pg=PA268|year=2005|publisher=McGraw-Hill Professional|isbn=978-0-07-142322-9|page=268}}</ref>
Most [[liver disease]]s cause only mild symptoms initially, but these diseases must be detected early. Hepatic (liver) involvement in some diseases can be of crucial importance. This testing is performed on a patient's blood sample. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., [[transaminase]]), and some with conditions linked to the biliary tract ([[gamma-glutamyl transferase]] and [[alkaline phosphatase]]). Because some of these tests do not measure function, it is more accurate to call these liver chemistries or liver tests rather than liver function tests.<ref>{{Cite journal|last1=Kwo|first1=Paul Y.|last2=Cohen|first2=Stanley M.|last3=Lim|first3=Joseph K.|date=January 2017|title=ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries|url=https://dx.doi.org/10.1038%2Fajg.2016.517|journal= American Journal of Gastroenterology|language=en-US|volume=112|issue=1|pages=18–35|doi=10.1038/ajg.2016.517|pmid=27995906|s2cid=23788795|issn=0002-9270|url-access=subscription}}</ref>
Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease. They can help distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on individuals taking certain medications, such as anticonvulsants, to ensure that these medications are not adversely impacting the person's liver.{{citation needed|date=May 2022}}
Line 22:
Standard liver tests for assessing liver damage include alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). Bilirubin may be used to estimate the excretory function of the liver and coagulation tests and albumin can be used to evaluate the metabolic activity of the liver.<ref name="Shivaraj 2009"/>
Although example reference ranges are given, these will vary depending on method of analysis used at the administering laboratory, as well as age, gender, ethnicity, and potentially unrelated health factors. Individual results should always be interpreted using the reference range provided by the laboratory that performed the test.<ref>{{
===Total bilirubin===
Line 110:
| 3.5 to 5.3 g/dL
|}
[[Albumin]] is a protein made specifically by the liver, and can be measured cheaply and easily. It is the main constituent of total protein (the remaining constituents are primarily [[globulins]]). Albumin levels are decreased in chronic liver disease, such as [[cirrhosis]]. It is also decreased in [[nephrotic syndrome]], where it is lost through the urine. The consequence of low albumin can be edema since the intravascular [[oncotic pressure]] becomes lower than the extravascular space. An alternative to albumin measurement is prealbumin, which is better at detecting acute changes (half-life of albumin and prealbumin is about 2 weeks and about 2 days, respectively).<ref>{{Cite journal|last=Smith|first=Susan H.|date=April 2017|title=Using albumin and prealbumin to assess nutritional status|url=https://dx.doi.org/10.1097%2F01.NURSE.0000511805.83334.df|journal=Nursing2021|language=en-US|volume=47|issue=4|pages=65–66|doi=10.1097/01.NURSE.0000511805.83334.df|pmid=28328780|s2cid=45694428 |issn=0360-4039|url-access=subscription}}</ref><ref>{{Cite web|title=Prealbumin Blood Test: MedlinePlus Medical Test|url=https://medlineplus.gov/lab-tests/prealbumin-blood-test/|access-date=2021-02-25|website=medlineplus.gov|language=en}}</ref>
== Other tests ==
| |||